Trials / Unknown
UnknownNCT00317928
Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Aarhus University Hospital Skejby · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: Metformin treatment normalises hormone values and metabolic parameters in women with PCOS. Ovulation is restored and bleeding periods become regular. Fifty women with PCOS (Rotterdam criteria) are randomised to either placebo or metformin for 6 months. After a wash-out period of 3 months, the opposite treatment is given for another 6 months. Measurements are performed before ech treatment period, every second month during treatment and after completing treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin |
Timeline
- Start date
- 2001-08-01
- Completion
- 2004-09-01
- First posted
- 2006-04-25
- Last updated
- 2006-10-11
Source: ClinicalTrials.gov record NCT00317928. Inclusion in this directory is not an endorsement.